Yuko Arioka

2.2k total citations
35 papers, 966 citations indexed

About

Yuko Arioka is a scholar working on Molecular Biology, Genetics and Biological Psychiatry. According to data from OpenAlex, Yuko Arioka has authored 35 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Genetics and 9 papers in Biological Psychiatry. Recurrent topics in Yuko Arioka's work include Pluripotent Stem Cells Research (10 papers), Genetics and Neurodevelopmental Disorders (10 papers) and Tryptophan and brain disorders (9 papers). Yuko Arioka is often cited by papers focused on Pluripotent Stem Cells Research (10 papers), Genetics and Neurodevelopmental Disorders (10 papers) and Tryptophan and brain disorders (9 papers). Yuko Arioka collaborates with scholars based in Japan and United States. Yuko Arioka's co-authors include Kuniaki Saito, Yasuhiro Yamada, Yasuko Yamamoto, Mitsuru Seishima, Masato Hoshi, Hisataka Moriwaki, Masahito Shimizu, Hiroyasu Ito, Yuki Murakami and Katsunori Semi and has published in prestigious journals such as Cell, The Journal of Immunology and PLoS ONE.

In The Last Decade

Yuko Arioka

33 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Arioka Japan 16 556 165 152 110 86 35 966
Anna Engler Switzerland 18 458 0.8× 133 0.8× 55 0.4× 107 1.0× 129 1.5× 30 1.2k
Anna Boyajyan Armenia 17 253 0.5× 252 1.5× 91 0.6× 226 2.1× 106 1.2× 47 802
Beatriz Moreno Spain 19 438 0.8× 87 0.5× 55 0.4× 298 2.7× 78 0.9× 35 1.2k
Beyhan Cengiz Türkiye 17 439 0.8× 82 0.5× 54 0.4× 63 0.6× 61 0.7× 54 1.1k
Milena Zanzottera Italy 19 326 0.6× 80 0.5× 114 0.8× 224 2.0× 60 0.7× 49 1000
Linnéa Asp Sweden 11 311 0.6× 246 1.5× 27 0.2× 99 0.9× 103 1.2× 13 1000
Lara Kular Sweden 19 608 1.1× 58 0.4× 101 0.7× 255 2.3× 57 0.7× 35 1.1k
Klaus Dieterich France 17 442 0.8× 38 0.2× 234 1.5× 44 0.4× 92 1.1× 49 970
Hyeon-Sook Suh United States 12 273 0.5× 159 1.0× 35 0.2× 253 2.3× 64 0.7× 12 856
Rinat Gizatullin Sweden 18 441 0.8× 54 0.3× 95 0.6× 59 0.5× 101 1.2× 37 750

Countries citing papers authored by Yuko Arioka

Since Specialization
Citations

This map shows the geographic impact of Yuko Arioka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Arioka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Arioka more than expected).

Fields of papers citing papers by Yuko Arioka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Arioka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Arioka. The network helps show where Yuko Arioka may publish in the future.

Co-authorship network of co-authors of Yuko Arioka

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Arioka. A scholar is included among the top collaborators of Yuko Arioka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Arioka. Yuko Arioka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayashi, Yu, Hiroki Okumura, Yuko Arioka, et al.. (2024). Analysis of human neuronal cells carrying ASTN2 deletion associated with psychiatric disorders. Translational Psychiatry. 14(1). 236–236. 1 indexed citations
2.
Okumura, Hiroki, Yu Hayashi, Yuko Arioka, et al.. (2024). Generation of induced pluripotent stem cells from a schizophrenia patient with heterozygous 1q21.1 deletion. Stem Cell Research. 81. 103555–103555.
3.
Arioka, Yuko, Hiroki Okumura, Hideya Sakaguchi, & Norio Ozaki. (2023). Shedding light on latent pathogenesis and pathophysiology of mental disorders: The potential ofiPScell technology. Psychiatry and Clinical Neurosciences. 77(6). 308–314. 2 indexed citations
4.
Ishikawa, Masaki, Yasuko Yamamoto, Kazuo Kunisawa, et al.. (2023). Indoleamine 2,3‐dioxygenase 2 deficiency associates with autism‐like behavior via dopaminergic neuronal dysfunction. FEBS Journal. 291(5). 945–964. 1 indexed citations
5.
Okumura, Hiroki, Yuko Arioka, Itaru Kushima, Daisuke Mori, & Norio Ozaki. (2022). Establishment of induced pluripotent stem cells from a patient with 16p13.11 duplication and VPS13B deletion. Stem Cell Research. 64. 102884–102884. 3 indexed citations
6.
Arioka, Yuko, Emiko Shishido, Itaru Kushima, et al.. (2020). Chromosome 22q11.2 deletion causes PERK-dependent vulnerability in dopaminergic neurons. EBioMedicine. 63. 103138–103138. 20 indexed citations
7.
Arioka, Yuko, Emiko Shishido, Itaru Kushima, Daisuke Mori, & Norio Ozaki. (2020). Cell body shape and directional movement stability in human-induced pluripotent stem cell-derived dopaminergic neurons. Scientific Reports. 10(1). 5820–5820. 1 indexed citations
8.
Sobue, Akira, Itaru Kushima, Taku Nagai, et al.. (2018). Genetic and animal model analyses reveal the pathogenic role of a novel deletion of RELN in schizophrenia. Scientific Reports. 8(1). 13046–13046. 38 indexed citations
9.
Arioka, Yuko, et al.. (2018). Induced pluripotent stem cells derived from a schizophrenia patient with ASTN2 deletion. Stem Cell Research. 30. 81–84. 7 indexed citations
10.
Arioka, Yuko, Hiroyasu Ito, Akihiro Hirata, et al.. (2017). Behavior of leucine-rich repeat-containing G-protein coupled receptor 5-expressing cells in the reprogramming process. Stem Cell Research. 20. 1–9. 4 indexed citations
11.
Ito, Hiroyasu, Tatsuya Ando, Yuko Arioka, et al.. (2016). The Deficiency of Indoleamine 2,3-Dioxygenase Aggravates the CCl4-Induced Liver Fibrosis in Mice. PLoS ONE. 11(9). e0162183–e0162183. 20 indexed citations
12.
Kimura, Hiroki, Chenyao Wang, Kanako Ishizuka, et al.. (2016). Resequencing and Association Analysis of Six PSD-95-Related Genes as Possible Susceptibility Genes for Schizophrenia and Autism Spectrum Disorders. Scientific Reports. 6(1). 27491–27491. 49 indexed citations
13.
Ishizuka, Kanako, Hiroki Kimura, Chenyao Wang, et al.. (2016). Investigation of Rare Single-Nucleotide PCDH15 Variants in Schizophrenia and Autism Spectrum Disorders. PLoS ONE. 11(4). e0153224–e0153224. 15 indexed citations
14.
Ito, Hiroyasu, et al.. (2015). Inhibition of indoleamine 2,3-dioxygenase activity accelerates skin wound healing. Biomaterials. 53. 221–228. 20 indexed citations
15.
Arioka, Yuko, Hiroyasu Ito, Tatsuya Ando, et al.. (2015). Pre-stimulated Mice with Carbon Tetrachloride Accelerate Early Liver Regeneration After Partial Hepatectomy. Digestive Diseases and Sciences. 60(6). 1699–1706. 1 indexed citations
16.
Ohnishi, K, Katsunori Semi, Takuya Yamamoto, et al.. (2014). Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation. Cell. 156(4). 663–677. 335 indexed citations
18.
Yamamoto, Yasuko, Katsuya Okawa, Tadao Funato, et al.. (2013). Acquired resistance of leukemic cells to AraC is associated with the upregulation of aldehyde dehydrogenase 1 family member A2. Experimental Hematology. 41(7). 597–603.e2. 16 indexed citations
19.
Arioka, Yuko, Yasuko Yamamoto, Masato Hoshi, et al.. (2012). Pre-administration of L-tryptophan improved ADR-induced early renal failure in mice. Life Sciences. 91(3-4). 100–106. 5 indexed citations
20.
Arioka, Yuko, Akira Watanabe, Kuniaki Saito, & Yasuhiro Yamada. (2012). Activation-Induced Cytidine Deaminase Alters the Subcellular Localization of Tet Family Proteins. PLoS ONE. 7(9). e45031–e45031. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026